A. , O. O. Farewell, V. T. Deangelis, D. Day, N. E. Gill et al., New therapy explains the fall in AIDS incidence with a substantial rise in number of persons on treatment expected, AIDS, vol.13108, issue.103, 1999.

A. , G. M. Mcmenamin, J. J. Parpia, T. Gibbs, J. Mcsharry et al., The recent impact of antiretroviral combination therapy on CD4 counts, AIDS and death in HIV-infected persons: routine HIV surveillance in Scotland, International Journal of STD and AIDS, vol.9, pp.561-566, 1998.

A. , F. Visona, G. Bruno, R. De-carli, G. Apolone et al., Health-related quality of life in asymptomatic patients with HIV: evaluation of the SF-36 health survey in Italian patients, Pharmacoeconomics, vol.18, issue.1, pp.63-72, 2000.

A. , S. M. Clore, J. N. Kiesler, D. J. Orr, T. Pegg et al., Relation of diabetic patients' health-related control appraisals and physician Á/patient interpersonal impacts to patients' metabolic control and satisfaction with treatment, Journal of Behavioral Medecine, vol.25, issue.1, pp.17-31, 2002.

A. C. Blalock, J. S. Mcdaniel, and E. W. Farber, Effect of Employment on Quality of Life and Psychological Functioning in Patients With HIV/AIDS, Psychosomatics, vol.43, issue.5, pp.400-404, 2002.
DOI : 10.1176/appi.psy.43.5.400

B. , F. Morlat, P. Chene, G. Mercie, P. Neau et al., Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, HIV Medicine, vol.3, issue.3, p.195, 0199.

B. , R. Wu, A. W. Floridia, M. Fragola, V. Ricciardulli et al., Quality of life outcomes of combination zidovudine-didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients, AIDS, issue.16, pp.14-2567, 2000.

C. , C. Langius-eklof, A. Lidman, K. Wredling, and R. , Gender differences in perceived healthrelated quality of life among patients with HIV infection, AIDS Patient Care and STDS, vol.15, issue.1, pp.31-39, 2001.

C. , C. Langius-eklof, A. Lidman, K. Wredling, and R. , Self-reported adherence to antiretroviral treatment and degree of sense of coherence in a group of HIV-infected patients, AIDS Patient Care and STDS, issue.12, pp.16-609, 2002.

C. , J. A. Cohen, M. H. Burke, J. Grey, D. Anastos et al., Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women, Journal of Acquired Immune Deficiency Syndrome, vol.30, issue.4, pp.401-409, 2002.

C. , J. E. Pesa, and J. A. , Assessing quality of life in women living with HIV infection, AIDS Care, vol.14, issue.2, pp.235-245, 2002.

C. , J. S. Spino, C. Grimes, J. Wofsy, C. B. Katzenstein et al., Differences between women and men in adverse events and CD4'/ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team, Journal of Acquired Immune Deficiency Syndrome, vol.24, issue.4, pp.316-324, 2000.

D. , S. Lazzarini, L. Cattelan, A. Meneghetti, F. Novara et al., Evaluation of adherence to antiretroviral therapy in Italian HIV patients, AIDS Patient Care and STDS, vol.17, issue.1, pp.33-41, 2003.

F. , J. Renwick, R. Mccoll, and M. , Coping and social support as determinants of quality of life in HIV, AIDS. AIDS Care, vol.8, issue.1, pp.15-31, 1996.

G. , M. Bevia, B. Medina, E. Talero, and M. S. , Quality of the physician Á/patient relation and results of clinical encounters in primary care in Alicante: a study with focal groups, Rev Esp Salud Publica, issue.5, pp.76-561, 2002.

G. , G. H. Jaeschke, and R. J. , Reassessing quality-of-life instruments in the evaluation of new drugs, Pharmacoeconomics, vol.12, issue.6, pp.621-626, 1997.

H. , G. S. Shearer, and A. G. , Beliefs that support the behavior of people with asthma: a qualitative investigation, Journal of Asthma, vol.38, issue.5, pp.427-434, 2001.

K. , M. H. Douglas, J. M. Jr, G. A. Bolan, R. Marx et al., Depression and use of mental health services among HIV-infected men, AIDS Care, vol.8, issue.4, pp.433-442, 1996.

L. , P. Leseth, A. Matheson, and I. , The doctor Á/patient relationship and the management of asthma, Social Science and Medicine, vol.47, issue.1, pp.85-91, 1998.

L. , A. Ecosse, E. Pouchot, J. Coste, J. Perneger et al., Le questionnaire SF-36, 2001.

L. , A. Mesbah, M. &. Marquis, and P. , Preliminary analysis of the psychometric properties of the French version of an international questionnaire measuring the quality of life: the MOS SF-36 (version 1.1), pp.371-379, 1995.

L. , K. Y. Zeger, S. L. Lutgendorf, S. K. Anderson, B. Ullrich et al., Longitudinal data analysis using generalized linear models 13 Á/22 Quality of life and mood in women with gynecologic cancer: a one-year prospective study, Biometrika Cancer, vol.73, issue.941, pp.131-140, 1986.

M. , W. D. Murphy, and D. A. , Effects of empowerment among HIV-positive women on the patient Á/ provider relationship, AIDS Care, vol.15, issue.4, pp.475-481, 2003.

M. , C. A. Ware, J. E. Jr, L. , J. F. Sherbourne et al., The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups, Medical Care, vol.32, issue.1, pp.40-66, 1994.

M. , C. A. Ware, J. E. Jr, and A. E. Raczek, The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs, Medical Care, issue.3, pp.31-247, 1993.

M. , A. H. Sabin, C. A. Mocroft, A. Youle, M. Fisher et al., Health-related quality of life in individuals infected with HIV in the era of HAART, HIV Clinical Trials, vol.2, issue.6, pp.484-492, 2001.

M. , A. Vella, S. Benfield, T. Chiesi, A. Miller et al., Changing patterns of mortality across Europe in patients infected with HIV-1, Lancet, vol.352, pp.1725-1730, 1998.

M. , Y. Alfandari, S. Valette, M. Cartier, F. Dellamonica et al., Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres, AIDS, vol.11, issue.F101, 1997.

N. , P. T. Gisolf, E. H. Colebunders, R. Wu, A. W. Danner et al., Quality of life in asymptomatic and symptomatic HIV-infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group, AIDS, vol.14, issue.2, pp.181-187, 2000.

O. , I. Pomeroy, and C. , Sex differences in adverse reactions to antiretroviral drugs, Top HIV Medicine, vol.11, issue.2, pp.55-59, 2003.

R. , M. Fliege, H. Hildebrandt, M. Schirop, T. Klapp et al., The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control, Diabetes Care, vol.25, issue.1, pp.35-42, 2002.

R. , M. J. Miller, and S. , Secondary prevention for youths living with HIV, AIDS Care, vol.10, issue.1, pp.17-34, 1998.

R. , M. J. , D. A. Wight, R. G. Lee, M. B. Lightfoot et al., Improving the quality of life among young people living with HIV, Evaluation and Program Planning, vol.24, issue.2, pp.227-237, 2001.

S. , S. A. Radomsky, A. S. Otto, M. W. Salomon, and E. , Predictors of psychological well-being in a diverse sample of HIV-positive patients receiving highly active antiretroviral therapy, Psychosomatics, issue.6, pp.43-478, 2002.

S. , R. L. Seals, B. F. Moneyham, L. Demi, A. Cohen et al., Quality of life in HIV-infected women in the south-eastern United States, AIDS Care, vol.9, issue.5, pp.501-512, 1997.

S. , S. Mohr, J. Justis, J. C. Berman, S. Squier et al., Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness, International Journal of STDs and AIDS, vol.10, issue.6, pp.383-391, 1999.

T. , C. Karlsson, J. Sullivan, and M. , Do SF-36 summary component scores accurately summarize subscale scores?, Quality of Life Research, vol.10, issue.5, pp.395-404, 2001.

T. , D. Desiderio, F. Ravaioli, A. Sartori, and S. , Patient Á/physician relation and unproven therapies, Journal of Clinical Oncology, vol.16, issue.9, p.3203, 1998.

T. , E. M. Baker, R. K. Moorman, A. C. Alzola, C. F. Furhrer et al., Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy, Clinical Infectious Disease, vol.36, issue.3, pp.363-367, 2003.

T. , R. A. Barr, and M. , Impact of combination therapy for HIV infection on inpatient census, New England Journal of Medicine, vol.336, issue.21, pp.1531-1532, 1997.

W. , J. E. Jr, and C. D. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Medical Care, vol.30, issue.6, pp.473-483, 1992.

W. , J. E. Jr, G. , B. Kosinski, M. Aaronson et al., The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment, Journal of Clinical Epidemiology, issue.11, pp.51-1167, 1998.

W. , J. E. Jr, M. Kosinski, M. S. Bayliss, C. A. Mchorney et al., Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study, Medical Care, vol.33, issue.4, pp.264-279, 1995.

W. , I. B. Jacobson, D. L. Roubenoff, R. Spiegelman, D. Knox et al., Changes in lean body mass and total body weight are weakly associated with physical functioning in patients with HIV infection, HIV Medicine, vol.3270, issue.263, 2002.

W. , A. W. Jacobson, K. L. Frick, K. D. Clark, R. Revicki et al., Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial, Quality of Life Research, vol.11, issue.3, pp.273-282, 2002.

Z. , S. L. Liang, and K. Y. , Longitudinal data analysis for discrete and continuous outcomes, Biometrics, vol.42, issue.1, pp.121-130, 1986.